Gene therapy corrects the cardiac effects of Friedreich’s ataxia – EurekAlert

Provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications.
CREDIT: Mary Ann Liebert, Inc., publishers

Gene therapy was successfully used to overcome the cardiac effects of Freidreich’s ataxia (FA) in a mouse model of the disease, as reported in the peer-reviewed journal Human Gene Therapy. Click here to read the full-text article free online through October 18, 2020.

Researchers at Weill Cornell Medical College created a unique, cardiac-specific mouse model of FA that is similar to early stage human disease. The mice are normal at rest but exhibit stress-induced cardiac symptoms, such as when they exercise on a treadmill.

Click here to read full article

Font Resize